Pulse Biosciences, Inc. announced a collaboration with CardioNXT, to support Pulse Biosciences? planned nsPFA cardiac catheter first-in-human study focused on the treatment of atrial fibrillation. The collaboration will include full integration of Pulse Biosciences?

nsPFA circumferential cardiac catheter and CardioNXT?s iMap Navigation and Mapping System, enabling electrophysiologists to successfully visualize individual cardiac structures and place the nsPFA catheter for circumferential ablations of targeted pulmonary veins in the treatment of atrial fibrillation.